Nurix Therapeutics Stock Price Prediction
| NRIX Stock | USD 19.14 0.35 1.80% |
Oversold Vs Overbought
42
Oversold | Overbought |
EPS Estimate Current Year (2.77) | EPS Estimate Next Year (2.74) | Wall Street Target Price 31.9412 | EPS Estimate Current Quarter (0.69) | Quarterly Revenue Growth (0.32) |
Using Nurix Therapeutics hype-based prediction, you can estimate the value of Nurix Therapeutics from the perspective of Nurix Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Nurix Therapeutics using Nurix Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Nurix using crowd psychology based on the activity and movement of Nurix Therapeutics' stock price.
Nurix Therapeutics Implied Volatility | 1.01 |
Nurix Therapeutics' implied volatility exposes the market's sentiment of Nurix Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Nurix Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Nurix Therapeutics stock will not fluctuate a lot when Nurix Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Nurix Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Nurix because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Nurix Therapeutics after-hype prediction price | USD 19.14 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Nurix contract
Based on the Rule 16, the options market is currently suggesting that Nurix Therapeutics will have an average daily up or down price movement of about 0.0631% per day over the life of the 2025-04-17 option contract. With Nurix Therapeutics trading at USD 19.14, that is roughly USD 0.0121 . If you think that the market is fully incorporating Nurix Therapeutics' daily price movement you should consider acquiring Nurix Therapeutics options at the current volatility level of 1.01%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Nurix |
Nurix Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Nurix Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nurix Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Nurix Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nurix Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Nurix Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nurix Therapeutics' historical news coverage. Nurix Therapeutics' after-hype downside and upside margins for the prediction period are 15.42 and 22.86, respectively. We have considered Nurix Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nurix Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Nurix Therapeutics is based on 3 months time horizon.
Nurix Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Nurix Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nurix Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nurix Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.39 | 3.69 | 0.64 | 0.01 | 10 Events / Month | 12 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
19.14 | 19.14 | 0.00 |
|
Nurix Therapeutics Hype Timeline
Nurix Therapeutics is now traded for 19.14. The entity has historical hype elasticity of -0.64, and average elasticity to hype of competition of -0.01. Nurix is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -0.39%. %. The volatility of related hype on Nurix Therapeutics is about 12300.0%, with the expected price after the next announcement by competition of 19.13. About 98.0% of the company shares are owned by institutional investors. The book value of Nurix Therapeutics was now reported as 5.62. The company recorded a loss per share of 2.85. Nurix Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Nurix Therapeutics Basic Forecasting Models to cross-verify your projections.Nurix Therapeutics Related Hype Analysis
Having access to credible news sources related to Nurix Therapeutics' direct competition is more important than ever and may enhance your ability to predict Nurix Therapeutics' future price movements. Getting to know how Nurix Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nurix Therapeutics may potentially react to the hype associated with one of its peers.
Nurix Therapeutics Additional Predictive Modules
Most predictive techniques to examine Nurix price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nurix using various technical indicators. When you analyze Nurix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Nurix Therapeutics Predictive Indicators
The successful prediction of Nurix Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nurix Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nurix Therapeutics based on analysis of Nurix Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nurix Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nurix Therapeutics's related companies. | 2021 | 2022 | 2024 (projected) | Current Ratio | 4.51 | 3.4 | 3.06 | Net Debt To EBITDA | 0.3 | 0.17 | 0.2 |
Story Coverage note for Nurix Therapeutics
The number of cover stories for Nurix Therapeutics depends on current market conditions and Nurix Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nurix Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nurix Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Nurix Therapeutics Short Properties
Nurix Therapeutics' future price predictability will typically decrease when Nurix Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nurix Therapeutics often depends not only on the future outlook of the potential Nurix Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nurix Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 54.3 M | |
| Cash And Short Term Investments | 287.9 M |
Additional Tools for Nurix Stock Analysis
When running Nurix Therapeutics' price analysis, check to measure Nurix Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix Therapeutics is operating at the current time. Most of Nurix Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nurix Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nurix Therapeutics' price. Additionally, you may evaluate how the addition of Nurix Therapeutics to your portfolios can decrease your overall portfolio volatility.